Search

Search Constraints

You searched for: Author/Creator Johnson, Faye M.

Search Results

1. A Phase I/II Study Combining Erlotinib and Dasatinib for Non-Small Cell Lung Cancer. (28th August 2014)

2. A Phase I/II Study Combining Erlotinib and Dasatinib for Non‐Small Cell Lung Cancer. (28th August 2014)

3. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus–associated oropharyngeal cancer. (23rd November 2015)

4. Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants. (1st September 2018)

5. Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Issue 8 (11th December 2020)

6. Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck. Issue 5 (1st February 2021)

8. Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancers. Issue 8 (September 2015)

9. Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancers. Issue 8 (September 2015)